Potentiation of the anti-tumour effect of docetaxel by conjugated linoleic acids (CLAs) in breast cancer cells in vitro

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 77, Issue 2, 2007, Pages 87-96

  Fite, Alemu ^a   Goua, Marie ^b   Wahle, Klaus W J ^b   Schofield, Andrew C ^a   Hutcheon, Andrew W ^a   Heys, Steven D ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROBERT GORDON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED LINOLEIC ACID; DOCETAXEL; NITROBLUE TETRAZOLIUM;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN; CELL STRAIN MCF 7; CELL VIABILITY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; IC 50; IN VITRO STUDY; INCUBATION TIME; ISOMER; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; HUMANS; LINOLEIC ACIDS, CONJUGATED; PILOT PROJECTS; STEREOISOMERISM; TAXOIDS;

EID: 35148837738     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.08.004     Document Type: Article

References (30)

1. Bissery M.C., Guenard D., Gueritte-Voegelein F., and Lavelle F. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 51 18 (1991) 4845-4852
2. Chevallier B., Fumoleau P., Kerbrat P., Dieras V., Roche H., Krakowski I., et al. Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer. J Clin. Oncol 13 2 (1995) 314-322
3. Cortes J.E. Pazdur R. Docetaxel,. J. Clin. Oncol 13 (1995) 2643-2655
4. Reinecke P., Schmitz M., Schneider E.M., Gabbert H.E., and Gerharz C.D. Multidrug resistance phenotype and paclitaxel (Taxol) sensitivity in human renal carcinoma cell lines of different histologic types. Cancer Invest 18 (2000) 614-625
5. Bougnoux P., Germain E., Chajes V., Hubert B., Lhuillery C., Le Floch O., et al. Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma. Br J Cancer 79 11-12 (1999) 1765-1769
6. Menendez J.A., del Mar Barbacid M., Montero S., Sevilla E., Escrich E., Solanas M., Cortes-Funes H., and Colomer R. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur. J. Cancer 37 (2001) 402-413
7. Belury M.A., Nickel K., Bird C., and Wu Y. Dietary conjugated linoleic acid modulation of phorbol ester skin tumor promotion. Nutr Cancer 26 (1996) 149-157
8. Cunningham D., Harrison L., and Schultz T. Proliferative responses of normal human mammary and MCF-7 breast cancer cells to linoleic acid, conjugated linoleic acid and eicosanoid synthesis inhibitors in culture. Anticancer Res 17 (1997) 197-204
9. Ip C., Chin S.F., Scimeca J., and Pariza M. Mammary cancer prevention by conjugated dienoic derivatives of linoleic acid. Cancer Res 51 (1991) 6118-6124
10. Schultz T.D., Chew B.P., and Seaman W.R. Differential stimulatory and inhibitory responses of human MCF-7 breast cancer cells to linoleic acid and conjugated linoleic acid in culture. Anticancer Res 12 (1992) 2143-2146
11. S. Banni, S.D. Heys, K.W.J. Wahle, Conjugated linoleic acids (CLA's) in cancer prevention and treatment: animal studies and cellular mechanisms. In: Advances in Conjugated Linoleic Acid Research, vol 2, (Eds.), J-L Sebedio, WW Christie, R Adlof, AOCS Press, Champaign, IL, USA, 2003, Chapter 16; pp. 267-282.
12. Pariza M.W., Ha Y.L., Benjamin H., Sword J.T., Gruter A., Chin S.F., Storkson J., Faith N., and Albright K. Formation and action of anticarcinogenic fatty acids. Adv. Exp. Med. Biol. 289 (1991) 269
13. Ip M.M., Masso-Welch P.A., Shoemaker S.F., Shea-Eaton W.K., and Ip C. Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res 250 (1999) 22-34
14. Ferlini C., Di Stefano M., Marone M., Gaggini C., Ferrandina G., Riva A., Bombardelli E., De Pasqua A., Mancuso S., and Scambia G. The synergistic anti-tumour activity of ICI 182,780 in combination with docetaxel is mediated by P-glycoprotein inhibition. Endocrine-Related Cancer 5 (1998) 315-324
15. Carles G., Braguer D., Sabeur G., and Briand C. The effect of combining antitubulin agents on differentiated and undifferentiated human colon cancer cells. Anticancer Drugs 9 (1998) 209-221
16. Majumder B., Wahle K.W.J., Moir S., Schofield A., Choe S.N., Farquharson A., Grant I., and Heys S.D. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. FASEB J 16 (2002) 1447-1449
17. Ochoa J.J., Farquharson A.J., Grant I., Moffat L.E., Heys S.D., and Wahle K.W.J. Conjugated linoleic acids (CLA's) decrease prostate cancer cell proliferation: different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis 25 7 (2004) 1185-1191
18. Begin M.E., Ells G., Das U.N., and Horrobin D.F. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J. Natl. Cancer. Inst. 77 (1986) 1053-1062
19. Burns C.P., and Spector A.A. Membrane fatty acid modification in tumor cells: a potential therapeutic adjunct. Lipids 22 (1987) 178-184
20. Begin M.E., Das U.N., Ells G., and Horrobin D.F. Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukot. Med. 19 (1985) 177-186
21. Wahle K.W.J., and Heys S.D. Cell signal mechanisms. conjugated linoleic acids (CLAs) and anti-tumorigenesis, Prost Leuk. Essent. Fatty Acids 67 (2002) 183-186
22. Roche H.M., Terres A.M., Black I.B., Gibney M.J., and Kelleher D. Fatty acids and epithelial permeability: effect of conjugated linoleic acid in Caco-2 cells. Gut 48 (2001) 797-802
23. Wahle K.W.J., Heys S.D., and Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health. Progr. Lipid Res. 43 (2004) 553-587
24. Muramaki M., Miyake H., Hara I., and Kamidono S. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and docetaxel in a human prostate cancer PC-3 model. Int J Oncol 26 (2005) 623-628
25. Pienta K.J. Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer. Semin Oncol 28 4 Suppl 15 (2001) 3-7
26. Egawa C., Miyoshi Y., Takamura Y., Taguchi T., Tamaki Y., and Noguchi S. Decreased expression of BRCA2 mRNA predicts favorable response to docetaxel in breast cancer. Int J Cancer 95 (2001) 255-259
27. Song H.J., Sneddon A.A., Barker P.A., et al. Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells. Nutr. Cancer. 49 (2004) 100-108
28. Jiang W.G., Bryce R.P., and Horrobin D.F. Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Crit. Rev. Oncol. Hematol. 27 (1998) 179-209
29. Riserus U., Vessby B., Amilov J., and Basu S. Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 80 2 (2004) 279-283
30. Leung Y.H., and Liu R.H. trans-10, cis-12-conjugated linoleic acid isomer exhibits stronger oxyradical scavenging capacity than cis-9,trans-11-conjugated linoleic acid isomer. J. Agric. Food. Chem. 48 (2000) 5469-5475